Cytisin amidophosphate--the new cytoprotector.

Q4 Medicine
Zhaxybay Zhumadilov, Talgat Nurgozhin, Alexandr Gulyaev, Sabira Zhaugasheva, Arystan Gazaliyev, Bakytgul Ermekbayeva, Gulnara Abuova, Almas Kenessary
{"title":"Cytisin amidophosphate--the new cytoprotector.","authors":"Zhaxybay Zhumadilov,&nbsp;Talgat Nurgozhin,&nbsp;Alexandr Gulyaev,&nbsp;Sabira Zhaugasheva,&nbsp;Arystan Gazaliyev,&nbsp;Bakytgul Ermekbayeva,&nbsp;Gulnara Abuova,&nbsp;Almas Kenessary","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This article describes the results of a clinical study of O,O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.</p>","PeriodicalId":12860,"journal":{"name":"Hiroshima journal of medical sciences","volume":"61 3","pages":"45-9"},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hiroshima journal of medical sciences","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This article describes the results of a clinical study of O,O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

新型细胞保护剂——氨基磷酸胞丝蛋白。
本文描述了对健康志愿者和142例确诊为急性中毒性肝炎的患者进行O,O二甲基- n -胞氨酸化磷酸临床研究的结果。耐受性很好。该药物的疗效被认为是非常高的,与标准治疗相比,状态正常化所需的时间更短;在第一次注入后立即取得了显著的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hiroshima journal of medical sciences
Hiroshima journal of medical sciences Medicine-Medicine (all)
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信